Novartis | NOVN - Kapitał Własny I Rezerwy

Cena Akcji
113.34
Dzienna Zmiana
-1.38 -1.20%
Miesięcznie
-5.41%
Rocznie
20.84%
Q2 Prognozy TE
111.47




Kapitał Własny I Rezerwy Zmiana Data
AbbVie USD -3.27B 628M 2025-12
Alcon AG USD 22.03B 52M 2025-12
Almirall EUR 1.49B 24.03M 2025-12
Amgen USD 8.66B 961M 2025-12
AstraZeneca USD 48.67B 2.78B 2025-12
Autolus Therapeutics Ltd USD 178.13M 87.32M 2025-12
Bayer EUR 25.95B 3.75B 2025-12
Biogen USD 18.26B 49.3M 2025-12
Bristol-Myers Squibb USD 18.55B 1.06B 2025-09
Eli Lilly USD 26.54B 2.74B 2025-12
Fresenius EUR 18.62B 320M 2025-09
Fresenius Medical Care EUR 249.82M 12.7B 2025-12
Galapagos EUR 3.24B 788.91M 2025-12
Genmab DKK 5.85B 96M 2025-12
Gilead Sciences USD 22.62B 1.16B 2025-12
GlaxoSmithKline GBP 16.38B 229M 2025-12
GRIFOLS EUR 5.29B 108.05M 2025-12
Hikma Pharmaceutical USD 2.59B 42M 2025-12
J&J USD 81.19B 358M 2026-03
Lonza CHF 9.13B 513M 2025-12
Merck EUR 28.59B 344M 2025-12
Merck USD 51.85B 2.79B 2025-09
Novartis USD 46.13B 1.38B 2025-12
Novartis USD 46.13B 1.8B 2025-12
Novo Nordisk DKK 194.05B 24.15B 2025-12
Orion EUR 1.12B 162.1M 2026-03
Pfizer USD 92.8B 4.11B 2025-09
Philips EUR 10.58B 204M 2025-09
Recordati EUR 1.93B 57.32M 2025-09
Regeneron Pharmaceuticals USD 31.42B 166.7M 2026-03
Roche Holding CHF 33.8B 758M 2025-12
Sanofi EUR 72.81B 1.1B 2026-03
UCB EUR 10.87B 1.18B 2025-12